Skip to content
Catalyst

PapersPMID:37207866

Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.

Experimental eye research2023The record ↗

findings
4
compound
1
endpoints
4
PMID:37207866
  1. Finding, insufficient evidencelowersCCN2
  2. Finding, insufficient evidencelowersCOL1A1
  3. Finding, insufficient evidencelowersFN1
  4. Finding, insufficient evidencelowersACTA2
Study, every finding
in vitro · not in humans
Population, every finding
orbital fibroblasts from patients with thyroid-associated ophthalmopathy, treated with TGF-β1 to induce fibrosis

Study record

Design
in vitro / mechanistic study
Species
cells
Population
orbital fibroblasts (OFs) cultured from patients with thyroid-associated ophthalmopathy (TAO) and from non-TAO controls, pre-treated with lutein then challenged with TGF-β1 (fibrosis) or IL-1β (inflammation, oxidative stress)
Participants
not reported
Comparator
placebo
Duration
not reported
Endpoints measured
5